Aurora Cannabis Inc. (NASDAQ:ACB) Short Interest Update

Aurora Cannabis Inc. (NASDAQ:ACBGet Free Report) saw a large growth in short interest in the month of March. As of March 15th, there was short interest totalling 3,820,000 shares, a growth of 14.7% from the February 29th total of 3,330,000 shares. Currently, 24.5% of the shares of the stock are sold short. Based on an average trading volume of 1,500,000 shares, the short-interest ratio is presently 2.5 days.

Analyst Upgrades and Downgrades

Separately, Canaccord Genuity Group upgraded shares of Aurora Cannabis from a “hold” rating to a “buy” rating in a research report on Friday, February 9th.

View Our Latest Research Report on Aurora Cannabis

Institutional Investors Weigh In On Aurora Cannabis

Institutional investors have recently modified their holdings of the business. Yong Rong HK Asset Management Ltd bought a new position in Aurora Cannabis during the 3rd quarter worth approximately $878,000. Mirae Asset Global Investments Co. Ltd. increased its holdings in Aurora Cannabis by 6.3% during the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 2,888,202 shares of the company’s stock worth $1,690,000 after buying an additional 172,049 shares during the last quarter. CIC Wealth LLC increased its holdings in Aurora Cannabis by 403.5% during the third quarter. CIC Wealth LLC now owns 50,347 shares of the company’s stock worth $29,000 after buying an additional 40,347 shares during the last quarter. Thrive Wealth Management LLC acquired a new position in Aurora Cannabis during the third quarter worth $32,000. Finally, Vontobel Holding Ltd. increased its holdings in shares of Aurora Cannabis by 67.5% in the third quarter. Vontobel Holding Ltd. now owns 125,304 shares of the company’s stock valued at $73,000 after purchasing an additional 50,500 shares during the last quarter. Institutional investors and hedge funds own 47.63% of the company’s stock.

Aurora Cannabis Trading Down 7.6 %

ACB opened at $4.39 on Monday. The company has a current ratio of 3.79, a quick ratio of 2.45 and a debt-to-equity ratio of 0.14. The stock has a market capitalization of $239.43 million, a PE ratio of -1.51 and a beta of 2.32. Aurora Cannabis has a 1-year low of $2.84 and a 1-year high of $11.50. The firm has a 50-day moving average price of $3.70 and a two-hundred day moving average price of $4.64.

Aurora Cannabis (NASDAQ:ACBGet Free Report) last posted its quarterly earnings data on Thursday, February 8th. The company reported ($0.20) earnings per share for the quarter, missing the consensus estimate of ($0.10) by ($0.10). Aurora Cannabis had a negative net margin of 48.82% and a negative return on equity of 23.27%. The company had revenue of $53.34 million during the quarter, compared to analyst estimates of $45.94 million. As a group, equities analysts anticipate that Aurora Cannabis will post -0.85 earnings per share for the current fiscal year.

About Aurora Cannabis

(Get Free Report)

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.

Further Reading

Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.